Acrivon Therapeutics, Inc. Common Stock ACRV
ACRV
Acrivon Therapeutics, Inc. Common Stock CLTEF
Calliditas Therapeutics AB (publ) INMB
INmune Bio, Inc. ALGS
Aligos Therapeutics, Inc. RLMD
Relmada Therapeutics, Inc. PRLD
Prelude Therapeutics Incorporated TPST
Tempest Therapeutics, Inc. IUGNF
Imugene Limited PMVP
PMV Pharmaceuticals, Inc. BCAB
BioAtla, Inc.
Acrivon Therapeutics, Inc. Common Stock CLTEF
Calliditas Therapeutics AB (publ) INMB
INmune Bio, Inc. ALGS
Aligos Therapeutics, Inc. RLMD
Relmada Therapeutics, Inc. PRLD
Prelude Therapeutics Incorporated TPST
Tempest Therapeutics, Inc. IUGNF
Imugene Limited PMVP
PMV Pharmaceuticals, Inc. BCAB
BioAtla, Inc.
Performance
| Periode | ACRV | CLTEF | INMB | ALGS | RLMD | PRLD | TPST | IUGNF | PMVP | BCAB |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 12.96 % | -78.03 % | -74.80 % | 131.13 % | 590.36 % | 77.92 % | 65.11 % | -59.87 % | 54.82 % | 186.59 % |
| YTD | -67.84 % | -78.03 % | -62.27 % | -76.32 % | 353.23 % | 0.80 % | -7.97 % | -68.06 % | -11.76 % | 41.29 % |
| 1Y | -74.79 % | -78.03 % | -63.39 % | 30.43 % | 143.58 % | -35.05 % | -26.17 % | -76.87 % | -10.00 % | -56.84 % |
| 3Y | -89.00 % | -89.93 % | -71.60 % | -66.32 % | 25.93 % | -81.22 % | -50.63 % | -92.89 % | -88.92 % | -88.39 % |
| 5Y | -89.00 % | -93.45 % | -80.44 % | -97.46 % | -72.43 % | -96.76 % | -56.94 % | -79.53 % | -96.24 % | -97.20 % |
| 10Y | -89.00 % | -93.45 % | -76.72 % | -97.46 % | -36.25 % | -95.19 % | -99.57 % | -96.87 % | -96.40 % | -97.20 % |
| From the beginning | -89.00 % | -93.45 % | -76.72 % | -97.46 % | -83.00 % | -95.19 % | -99.39 % | -96.27 % | -96.40 % | -97.20 % |